Loading clinical trials...

A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT04911751

A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis

The study is designed to investigate efficacy and safety of KBL697 in patients with Moderate Plaque Type Psoriasis. KBL697 has been developed as a potential new treatment for Psoriatic Plaque.

Lead sponsor: KoBioLabs•6 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

WITHDRAWN

A Pilot Study to Explore the Role of Gut Flora in Psoriasis

NCT04099979 · Psoriasis, Psoriasis Vulgaris, and more

UNKNOWN

Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines

NCT05144165 · Psoriasis, Psoriasis Palmaris, and more

COMPLETEDPhase 1/2

A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis

NCT03630939 · Psoriatic Plaque

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 7, 2025Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment80

Start dateNov 2021

Last updatedJan 7, 2025

Condition

Psoriatic Plaque

Locations shown

Total Skin and Beauty Dermatology Center

Birmingham, Alabama

Southern California Dermatology, Inc

Santa Ana, California

Clinical Science Institute

Santa Monica, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 7, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions